Blastic Plasmacytoid Dendritic Cell Neoplasms
Fanny Julia(Lyon 1 Université), Tony Petrella(Hôpital Maisonneuve-Rosemont), Pierre Déchelotte(Inserm), Laurence Lamant(Centre National de la Recherche Scientifique), B. Vergier(Centre Hospitalier Universitaire de Bordeaux), S. Dalac(CHU Dijon Bourgogne), A. De Muret(Centre Hospitalier Universitaire de Tours), Philippe Courville(Université de Bordeaux), Stéphane Dalle(Hospices Civils de Lyon), Andrew Mitchell(Harvard University), Nicolás Ortonne(Inserm), Valérie Costes‐Martineau(Centre de Recherches en Cancérologie de Toulouse), Claire Delattre(Lyon 1 Université), Annie Lévy(Lyon 1 Université), Gérard Duru(Cythelia (France)), B. Balme(Université Claude Bernard Lyon 1), Marie‐Dominique Vignon‐Pennamen(Assistance Publique – Hôpitaux de Paris), A. Carlotti(Délégation Paris 5), Sylvie Fraitag(Hôpital Necker-Enfants Malades)
Cited by 144
Related Papers
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
|New England Journal of Medicine|2017|2.2k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k
Prevalence of eating disorders over the 2000–2018 period: a systematic literature review
|American Journal of Clinical Nutrition|2018|1.7k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.
|Journal of Clinical Oncology|1997|706